A secret sauce to the cure of the patients with the immunodeficiency disease X-SCID was bone marrow conditioning with the chemotherapy drug busulfan, according to a publication in the New England Journal of Medicine.
In a phone Q&A, Keith Perry, CIO of the Memphis, Tennessee-based organization, voiced his thoughts on interoperability, artificial intelligence and the health IT problem he wishes he could magically solve.
In an interview, Kyan Health Co-Founder and Chief Commercial Officer Konstantin Struck discussed how Kyan gives mid-market and enterprise employers access to premium workforce mental healthcare, at a price point that is affordable.
The study, conducted with St. Jude Children's Research Hospital, showed a 78 percent predictive sensitivity two days before the onset of infection.